Mirum Pharmaceuticals secures additional $68.5M PIPE from TCGX ahead of Bluejay acquisition

Mirum Pharmaceuticals, Inc.

1,000,000 shares at $68.48/share; ~$68.5M gross proceeds from TCGX.
Combined with Dec 2025 $200M PIPE raises total ~$268.5M to fund Bluejay acquisition.
Both PIPE and Bluejay acquisition expected to close in Q1 2026, subject to conditions.
Registration rights agreement provides for resale registration of the PIPE shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.